Overview
Shelby D. Reed, PhD, is Professor in the Departments of Population Health Sciences and Medicine at Duke University’s School of Medicine. She is the director of the Center for Informing Health Decisions and Therapeutic Area leader for Population Health Sciences at the Duke Clinical Research Institute (DCRI). She also is core faculty at the Duke-Margolis Center for Health Policy. Dr. Reed has over 20 years of experience leading multidisciplinary health outcomes research studies. Dr. Reed has extensive expertise in designing and conducting trial-based and model-based cost-effectiveness analyses of diagnostics, drugs and patient-centered interventions. In 2016, she co-founded the Preference Evaluation Research (PrefER) Group at the DCRI, and she currently serves as its director. She and the group are frequently sought to conduct stated-preference studies to inform regulatory decisions, health policy, care delivery, value assessment and clinical decision making with applied projects spanning a wide range of therapeutic areas. She served as President for ISPOR in 2017-2018, and she currently is Past-Chair of the Society’s Health Science Policy Council.
Areas of expertise: Health Economics, Health Measurement, Stated Preference Research, Health Policy, and Health Services Research
Current Appointments & Affiliations
Recent Publications
Stated-Preference Survey Design and Testing in Health Applications.
Journal Article Patient · May 2025 Following the conceptualization of a well-formulated and relevant research question, selection of an appropriate stated-preference method, and related methodological issues, researchers are tasked with developing a survey instrument. A major goal of design ... Full text Link to item CiteHow Well Are Women Represented in Authorship in HEOR? An Analysis of Value in Health: An ISPOR Report.
Journal Article Value Health · May 2025 OBJECTIVES: The aim of this study was to report women's authorship in Value in Health in terms of articles submitted to and accepted for publication before and during the COVID-19 pandemic to evaluate its potential impact on women's research productivity. ... Full text Link to item CitePatient preferences for treatment of chronic rhinosinusitis with nasal polyps.
Journal Article Rhinology · April 1, 2025 Choosing between revision endoscopic sinus surgery (ESS) versus biologic therapy for recurrent chronic rhinosinusitis with nasal polyposis (CRSwNP) is a complex, multifaceted decision that involves not only clinical and financial factors but also patient p ... Full text Link to item CiteRecent Grants
DCRI D-COHRe Partnership for Innovation, Improved Access, and Operational Capability for Decentralized Clinical Trials of Medical Countermeasures in Public Health Emergencies
ResearchCo Investigator · Awarded by Biomedical Advanced Research and Development Authority · 2024 - 2029Addressing Food Insecurity in Transplant and Cellular Therapy Patients with Healthcare-Community Partnerships
ResearchCo Investigator · Awarded by The University of Kansas Medical Center Research Institute, Inc · 2024 - 2029REHAB-HFpEF Trial - Year 3
ResearchPrincipal Investigator · Awarded by Wake Forest University · 2022 - 2027View All Grants